CopyMark Law Group
4.9/5
Drawing for REVMED

USPTO serial 98222645

REVMED

Reviewed by CopyMark Law Group

Reg. 7495209Status 700Registered
Filing date
Status date
Registration date
Sep 3, 2024
Examiner
CLONCH, ABIGAIL
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with REVMED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Melissa A. Nowak

Melissa A. Nowak CHRISTENSEN O'CONNOR JOHNSON KINDNESS1201 THIRD AVENUE, SUITE 3600SEATTLE, WA 98101United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of oncological and immune system related diseases and disordersACTIVEJan 12, 2024
042Pharmaceutical research and development; drug discovery services; providing information about medical and scientific research via a websiteACTIVEDec 13, 2023
044Providing medical information via a website; providing health information via a website; providing information to patients and healthcare professionals via a website relating to disease diagnosis, management, and treatment options in the field of oncological and immune system related diseases and disordersACTIVEDec 13, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 3, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 18, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 18, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 29, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 14, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 13, 2024XAECEXAMINER'S AMENDMENT ENTERED—
May 13, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 13, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
May 13, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
May 11, 2024AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
May 9, 2024DOCKASSIGNED TO EXAMINER—
May 9, 2024DOCKASSIGNED TO EXAMINER—
Mar 4, 2024AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Mar 4, 2024IUAFUSE AMENDMENT FILED—
Mar 4, 2024EAAUTEAS AMENDMENT OF USE RECEIVED—
Oct 18, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 17, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance